FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37807458> ?p ?o ?g. }

• Q37807458 description "2010 nî lūn-bûn" @default.
• Q37807458 description "2010年の論文" @default.
• Q37807458 description "2010年学术文章" @default.
• Q37807458 description "2010年学术文章" @default.
• Q37807458 description "2010年学术文章" @default.
• Q37807458 description "2010年学术文章" @default.
• Q37807458 description "2010年学术文章" @default.
• Q37807458 description "2010年學術文章" @default.
• Q37807458 description "2010年學術文章" @default.
• Q37807458 description "2010年學術文章" @default.
• Q37807458 description "2010年學術文章" @default.
• Q37807458 description "2010年學術文章" @default.
• Q37807458 description "2010年學術文章" @default.
• Q37807458 description "2010년 논문" @default.
• Q37807458 description "article científic" @default.
• Q37807458 description "article scientific" @default.
• Q37807458 description "article scientifique publié en 2010" @default.
• Q37807458 description "articol științific" @default.
• Q37807458 description "articolo scientifico" @default.
• Q37807458 description "artigo científico (publicado na 2010)" @default.
• Q37807458 description "artigo científico (publicado na 2010)" @default.
• Q37807458 description "artigo científico" @default.
• Q37807458 description "artikull shkencor" @default.
• Q37807458 description "artikulong pang-agham" @default.
• Q37807458 description "artykuł naukowy" @default.
• Q37807458 description "artículo científico publicado en 2010" @default.
• Q37807458 description "artículu científicu espublizáu en 2010" @default.
• Q37807458 description "bilimsel makale" @default.
• Q37807458 description "bài báo khoa học" @default.
• Q37807458 description "mokslinis straipsnis" @default.
• Q37807458 description "naučni članak" @default.
• Q37807458 description "scienca artikolo" @default.
• Q37807458 description "scientific article published on December 2010" @default.
• Q37807458 description "teaduslik artikkel" @default.
• Q37807458 description "tieteellinen artikkeli" @default.
• Q37807458 description "tudományos cikk" @default.
• Q37807458 description "vedecký článok" @default.
• Q37807458 description "vetenskaplig artikel" @default.
• Q37807458 description "videnskabelig artikel (udgivet 2010)" @default.
• Q37807458 description "vitenskapelig artikkel" @default.
• Q37807458 description "vitskapeleg artikkel" @default.
• Q37807458 description "vědecký článek" @default.
• Q37807458 description "wetenschappelijk artikel" @default.
• Q37807458 description "wissenschaftlicher Artikel" @default.
• Q37807458 description "επιστημονικό άρθρο" @default.
• Q37807458 description "мақолаи илмӣ" @default.
• Q37807458 description "мақолаи илмӣ" @default.
• Q37807458 description "наукова стаття, опублікована в грудні 2010" @default.
• Q37807458 description "научна статия" @default.
• Q37807458 description "научная статья" @default.
• Q37807458 description "научни чланак" @default.
• Q37807458 description "научни чланак" @default.
• Q37807458 description "գիտական հոդված" @default.
• Q37807458 description "מאמר מדעי" @default.
• Q37807458 description "سائنسی مضمون" @default.
• Q37807458 description "مقالة علمية نشرت في ديسمبر 2010" @default.
• Q37807458 description "مقالهٔ علمی" @default.
• Q37807458 description "২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q37807458 description "บทความทางวิทยาศาสตร์" @default.
• Q37807458 description "სამეცნიერო სტატია" @default.
• Q37807458 name "Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug" @default.
• Q37807458 name "Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug" @default.
• Q37807458 name "Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug" @default.
• Q37807458 type Item @default.
• Q37807458 label "Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug" @default.
• Q37807458 label "Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug" @default.
• Q37807458 label "Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug" @default.
• Q37807458 prefLabel "Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug" @default.
• Q37807458 prefLabel "Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug" @default.
• Q37807458 prefLabel "Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug" @default.
• Q37807458 P1433 Q37807458-50091EF9-6013-4C39-AD58-8191221F8A4F @default.
• Q37807458 P1476 Q37807458-86C72F16-DBCA-4F13-B430-4D822F2701BE @default.
• Q37807458 P2093 Q37807458-18221657-7261-4993-B55D-C4F1AEB2ACA8 @default.
• Q37807458 P2860 Q37807458-0938B6D4-0977-424A-8654-4E4A9628C7B2 @default.
• Q37807458 P2860 Q37807458-A970749B-2151-4D81-9529-C63FC741C763 @default.
• Q37807458 P304 Q37807458-50E8782E-2C9D-4E5C-9A62-71C93F103420 @default.
• Q37807458 P31 Q37807458-5FF0434A-F8CE-483C-A97C-F87279FFDDF2 @default.
• Q37807458 P356 Q37807458-E9B71A99-1820-4F19-89C1-DAD6C1EC0392 @default.
• Q37807458 P433 Q37807458-C18C2EF0-F45F-47B8-AD62-A9E20BCA3A31 @default.
• Q37807458 P478 Q37807458-4FDF1BCC-F410-4562-82EB-4D3051A3929B @default.
• Q37807458 P577 Q37807458-F252A919-CD7E-45A3-A16E-F306A216914C @default.
• Q37807458 P5875 Q37807458-4DD1F70A-1C32-4A34-8B69-1CD4F60734C9 @default.
• Q37807458 P698 Q37807458-C00C626F-C7E2-4488-9041-AD47D654B282 @default.
• Q37807458 P921 Q37807458-4968D31D-8B2D-416A-B270-0C24F462CC21 @default.
• Q37807458 P356 J.1365-2710.2009.01148.X @default.
• Q37807458 P698 21054456 @default.
• Q37807458 P1433 Q15753553 @default.
• Q37807458 P1476 "Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug" @default.
• Q37807458 P2093 "R E Kast" @default.
• Q37807458 P2860 Q36787477 @default.
• Q37807458 P2860 Q55486057 @default.
• Q37807458 P304 "657-663" @default.
• Q37807458 P31 Q13442814 @default.
• Q37807458 P356 "10.1111/J.1365-2710.2009.01148.X" @default.
• Q37807458 P433 "6" @default.
• Q37807458 P478 "35" @default.
• Q37807458 P577 "2010-12-01T00:00:00Z" @default.
• Q37807458 P5875 "47698465" @default.
• Q37807458 P698 "21054456" @default.
• Q37807458 P921 Q282142 @default.